Eric M. Lindenfeld

Eric Lindenfeld is a member of the firm’s Mass Tort Practice Group and focuses his practice on representing public entities as plaintiffs in complex litigation. Eric has played an integral role in litigation around the country, including in Minnesota v. JUUL, which settled favorably in 2023 on the eve of closing arguments. Eric was also a part of the trial and litigation teams in In Re: National Prescription Opiate Litigation, a consolidated suit in the Northern District of Ohio involving the national opioid crisis.

Eric earned his law degree, with honors, from the University of Minnesota. He has authored several scholarly articles in prominent law journals, including in the Yale Journal of Law and Technology and the Food and Drug Law Journal. His publications have been widely cited by law professors and practitioners, including in the Law, Medicine & Medical Technology, and the Food and Drug Administration casebooks.

In his free time, Eric enjoys hiking, watching documentaries, spending time with his niece and nephew, and of course, watching the Knicks win basketball games.

Education

University of Minnesota Law School, J.D., with honors

Queens College, B.A. in Economics

Representative Matters

• Named a “Minnesota Rising Star,” Super Lawyers (2024)
• Listed in The Best Lawyers in America: Ones to Watch (2024-2025 editions)
• Named "Attorney of the Year" by Minnesota Lawyer (2023)

Professional

• American Association for Justice
• Public Justice Foundation

Speeches

• Justice and Sovereignty: Representing Native Nations in the Digital Age
  ​Robins Kaplan LLP Trial Advocacy Seminar, Minneapolis, Minnesota (October 30, 2024)

Media Mentions

"Clear Evidence Clarified," Vol.75 Food and Drug Law Journal. 346 (2020)
"Brand Name Preemption," Vol. 72 Food and Drug Law Journal. 4 (2017)
"3D Printing of Medical Devices," 85 UMKC L. Rev. 1 (2016)
"Prescription Drugs and Design Defect Liability," 64 Drake L. Rev. 111 (2016)
"The Unintended Pregnancy Crisis," 17 Marq. Ben. & Soc. Welfare L. Rev. 2 (2016)
"Beyond Preemption of Generic Drug Claims," 45 Sw. L. Rev. 241 (2015)
"Strict Liability and 3D-Printed Medical Devices," Yale J.L. & Tech. (2015)
"Medical Malpractice Non-Economic Damage Caps," 41 T. Marshall L. Rev. 109 (2015)